Cargando…
Rheumatoid Factors: Clinical Applications
Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845430/ https://www.ncbi.nlm.nih.gov/pubmed/24324289 http://dx.doi.org/10.1155/2013/726598 |
_version_ | 1782293310618992640 |
---|---|
author | Ingegnoli, Francesca Castelli, Roberto Gualtierotti, Roberta |
author_facet | Ingegnoli, Francesca Castelli, Roberto Gualtierotti, Roberta |
author_sort | Ingegnoli, Francesca |
collection | PubMed |
description | Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part of the workup for the differential diagnosis of arthropathies. In clinical practice, it is recommended to measure anti-cyclic citrullinated peptide antibodies and rheumatoid factors together because anti-cyclic citrullinated peptide antibodies alone are only moderately sensitive, and the combination of the two markers improves diagnostic accuracy, especially in the case of early rheumatoid arthritis. Furthermore, different rheumatoid factor isotypes alone or in combination can be helpful when managing rheumatoid arthritis patients, from the time of diagnosis until deciding on the choice of therapeutic strategy. |
format | Online Article Text |
id | pubmed-3845430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38454302013-12-09 Rheumatoid Factors: Clinical Applications Ingegnoli, Francesca Castelli, Roberto Gualtierotti, Roberta Dis Markers Review Article Rheumatoid factors are antibodies directed against the Fc region of immunoglobulin G. First detected in patients with rheumatoid arthritis 70 years ago, they can also be found in patients with other autoimmune and nonautoimmune conditions, as well as in healthy subjects. Rheumatoid factors form part of the workup for the differential diagnosis of arthropathies. In clinical practice, it is recommended to measure anti-cyclic citrullinated peptide antibodies and rheumatoid factors together because anti-cyclic citrullinated peptide antibodies alone are only moderately sensitive, and the combination of the two markers improves diagnostic accuracy, especially in the case of early rheumatoid arthritis. Furthermore, different rheumatoid factor isotypes alone or in combination can be helpful when managing rheumatoid arthritis patients, from the time of diagnosis until deciding on the choice of therapeutic strategy. Hindawi Publishing Corporation 2013 2013-11-13 /pmc/articles/PMC3845430/ /pubmed/24324289 http://dx.doi.org/10.1155/2013/726598 Text en Copyright © 2013 Francesca Ingegnoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Ingegnoli, Francesca Castelli, Roberto Gualtierotti, Roberta Rheumatoid Factors: Clinical Applications |
title | Rheumatoid Factors: Clinical Applications |
title_full | Rheumatoid Factors: Clinical Applications |
title_fullStr | Rheumatoid Factors: Clinical Applications |
title_full_unstemmed | Rheumatoid Factors: Clinical Applications |
title_short | Rheumatoid Factors: Clinical Applications |
title_sort | rheumatoid factors: clinical applications |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845430/ https://www.ncbi.nlm.nih.gov/pubmed/24324289 http://dx.doi.org/10.1155/2013/726598 |
work_keys_str_mv | AT ingegnolifrancesca rheumatoidfactorsclinicalapplications AT castelliroberto rheumatoidfactorsclinicalapplications AT gualtierottiroberta rheumatoidfactorsclinicalapplications |